ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:1901741;positive regulation of myoblast fusion;9.0;1.0;0.896240625180289;9.628524252492122;353.2013099653272;6.8867018697843045;0.011821329983997786;0.7484268790654467;[CD53, CXCL9, TNFSF14, FLT3LG, MAPK14]
GO:0051092;positive regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.4401483168805;4.8283137373023015;0.009352610284359957;0.6950405016553352;[TNF, CLU, ICAM1, PYCARD, TNFSF11, TRIM25, PRKCH, BTK, PRKCQ, ADAM8, S100A9, S100A8, CARD11, TNFRSF11A, PRKCZ, NLRP3, S100A12, TGFB1, EIF2AK2, NFKB1, NFKB2, MYD88, CD40, ITGB2, CD36, CHUK, RIPK2, IL18, IRAK3, TRAF1, GREM1, PSMA6, IL1B, TLR6, TLR4, LTF, TLR2, NLRC4, NOD2, CD40LG]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[NRP1, ECM1, CD40, SERPINE1, ITGB2, ADM, BRCA1, PIK3C2A, ETS1, AQP1, CDH5, C3AR1, CTSH, CYP1B1, ITGB8, CD34, IL10, PPP1R16B, GHSR, ANXA1, ANXA3, GAB1, CYBB, SIRT1, F3, GREM1, IL1A, SFRP2, IL1B, ADAM12, AGTR1, CHI3L1, ENG, CX3CR1, C5AR1, TWIST1, PTGS2, DLL1, THBS1, C3, CXCR2, HMOX1, PLCG1, JUP, PLK2, TNFSF12, KLF4, LRG1, TEK]
GO:0002244;hematopoietic progenitor cell differentiation;4.0;0.811012628672052;0.655506314336026;8.935377071932177;21.066225782797595;5.395046993006588;7.050676185779127E-4;0.5259029541176994;[TOP2A, SPI1, TNFRSF13B, PLEK, SOX4, PDGFRA, ESCO2, KIT, HOXB4, HOXB3, RBM47, PLD4, GATA3, JAM3, TGFB1, ACE, INHBA, PTPRC, BCL2, PTPN6]
GO:0097368;establishment of Sertoli cell barrier;6.0;1.0;0.8231203125901445;9.628524252492122;53.96940310801916;8.16763571524637;0.0018063073527159906;0.7408135829017477;[ARID4A, FLNA, ARID4B, ICAM1]
GO:0070560;protein secretion by platelet;9.0;1.0;0.896240625180289;9.628524252492122;143.4971776666168;9.083926447120524;0.004802721397426183;0.8607930461318132;[PLEK]
GO:0014739;positive regulation of muscle hyperplasia;8.0;1.0;0.875;9.628524252492122;117.65934785475751;9.777073627680469;0.003937952486160401;0.875;[AIF1]
GO:0051926;negative regulation of calcium ion transport;8.0;0.7140352122741334;0.7320176061370667;8.890925309361343;69.46225493434336;5.666199763507158;0.0023248391606816524;0.6647697194109919;[FMR1, PTGS2, ICAM1, PLN, DRD4, TGFB1, GPR35, LILRB1, LILRB2, GEM, FKBP1B, BCL2, CALM3]
GO:2000352;negative regulation of endothelial cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;129.9263443150347;6.444869117505266;0.0043485178181058145;0.7258315315665724;[SERPINE1, TNFAIP3, GATA3, ICAM1, TEK]
GO:2000473;positive regulation of hematopoietic stem cell migration;8.0;1.0;0.875;9.628524252492122;201.08518903965808;9.083926447120524;0.006730140312236458;0.839552420951524;[PTPRC, CCR2]
GO:0019886;antigen processing and presentation of exogenous peptide antigen via MHC class II;5.0;1.0;0.7902410118609202;9.628524252492122;42.20009821028515;5.192106149009898;0.0014123993094755708;0.5557655617789146;[KIF11, IFI30, CTSS, HLA-DOA, HLA-DOB, AP2M1, HLA-DPA1, LAG3, FCER1G, DNM2, KIF2C, HLA-DQB1, HLA-DMA, HLA-DMB, RACGAP1, HLA-DQA2, HLA-DQA1, CD74, HLA-DRB4, CENPE, KIF18A, KIF26A, HLA-DPB1, HLA-DRA, FCGR2B, HLA-DRB1]
GO:1902042;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;10.0;0.9326813400603323;0.8815816818910864;9.589303539338841;425.73912115989816;6.193554689224359;0.014249105244888325;0.731979686697602;[SERPINE1, HMGB2, TNFAIP3, FASLG, BRCA1, ICAM1, HMOX1, DAPK1, TNFRSF10B, SFRP2, BCL2L1]
GO:0050849;negative regulation of calcium-mediated signaling;8.0;0.8259837884571596;0.7879918942285797;9.417215158824915;240.2984816065916;6.518977089658987;0.008042573924779611;0.7083807915285978;[PLEK, SLA2, FKBP1B, HOMER3, CALM3]
GO:1900027;regulation of ruffle assembly;8.0;0.8933024483968273;0.8216512241984136;9.446202695698167;51.76168527241457;6.444869117505266;0.001732417023575362;0.7045909063862833;[CYFIP1, NLGN1, CAV1, RHOG, TACSTD2, ICAM1, EPS8, EPS8L1, STAP1, EPS8L3, PFN1]
GO:0043113;receptor clustering;6.0;0.7671156992804218;0.7066781622303554;8.992535485772125;42.889232177334534;5.9928839937622085;0.0014354640031724087;0.6295966787287501;[NLGN1, ITGA4, ITGB2, THY1, ITGAL, DNAJA3, FLNA, ITGB7, SHANK3]
GO:2000406;positive regulation of T cell migration;10.0;0.7980440201809971;0.8142630219514189;9.461470167828956;351.7821234142529;6.518977089658987;0.011773831087318304;0.7486218033895181;[TNFSF14, CCL21, ITGA4, CCL20, CXCL13, AIF1, PYCARD, CXCL10, CXCL12, CCL5, XCL2, XCL1, ADAM8, CCR2]
GO:0002523;leukocyte migration involved in inflammatory response;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;29.137022145890857;7.379178354882098;9.751899096054872E-4;0.7004918368257019;[ITGB2, FFAR2, ADAM8, CCR6, SELE, S100A9, ELANE, S100A8, JAM3]
GO:2000648;positive regulation of stem cell proliferation;6.0;0.8653626801206646;0.7558016526504768;9.34084218004034;63.968874315823136;6.250713103064308;0.002140980655101363;0.6427820713687392;[CX3CR1, SMARCD3, LTBP3, PTPRC, EPCAM]
GO:0045660;positive regulation of neutrophil differentiation;10.0;1.0;0.9152410118609203;9.628524252492122;984.374594686783;9.777073627680469;0.032946131804547585;0.9152410118609203;[EVI2B]
GO:0034698;response to gonadotropin;5.0;0.7980440201809971;0.6892630219514189;9.223059144383958;25.223505691001428;6.444869117505266;8.44208035796484E-4;0.6198319182472036;[TGFBR3, CCNA2, GHSR, LHCGR, POR, INHBA, ICAM1]
GO:0030890;positive regulation of B cell proliferation;9.0;1.0;0.896240625180289;9.628524252492122;506.1565706318756;6.063501560976162;0.016940604907709607;0.706328376990269;[CDKN1A, CD40, TFRC, TNFSF13B, CD38, NCKAP1L, CD74, MEF2C, FCRL3, MIF, MSH6, BST1, PTPRC, BCL6, BCL2, CARD11, CD320]
GO:2000363;positive regulation of prostaglandin-E synthase activity;6.0;1.0;0.8231203125901445;9.628524252492122;43.017486512842105;8.67846133901236;0.001439756560360439;0.7669372290569613;[ITGAM, ITGB2, NOD2]
GO:0031623;receptor internalization;7.0;0.7248374789738407;0.7133381047441208;9.201080237665183;64.84818556283533;5.682729065458369;0.0021704104112101165;0.6415343939386686;[ACHE, CALCRL, LRP1, TFRC, ITGB2, ADM, ARRB1, ARRB2, CXCR1, CXCR2, CD36, AP2M1, SNCA, FCER1G, SYK, CAV1, LILRB1, DNM2, CEACAM1, RAB31, NEDD4, CD9, RAMP1]
GO:0071404;cellular response to low-density lipoprotein particle stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;56.74958382123113;7.004484905440688;0.0018993574991869968;0.6813299963962409;[ABCA1, FCER1G, SYK, ITGB2, CD9, CD36]
GO:0051017;actin filament bundle assembly;6.0;0.7866048967936545;0.7164227609869718;9.143016436710422;39.792633402144126;5.734022359845919;0.001331823628924752;0.6163584827319739;[ITGB5, ARRB1, AIF1, EPS8, PLS1, ACTN1, PAWR, ACTN4, SORBS1, MARCKS, ZYX, LCP1]
GO:0090557;establishment of endothelial intestinal barrier;7.0;1.0;0.8509193652572005;9.628524252492122;36.14219065488164;7.57984905034425;0.0012096465953590567;0.738553198190834;[F11R, ICAM1]
GO:0045429;positive regulation of nitric oxide biosynthetic process;8.0;1.0;0.875;9.628524252492122;658.6394256443023;6.166155715036245;0.02204406883931546;0.6903374900225189;[ITGB2, PTGS2, TNF, CLU, AIF1, ICAM1, KLRK1, AKT1, CD36, EDN1, AGXT2, KLF4, DNM2, IFNG, IL1B, PTX3, TLR6, TLR4]
GO:0090314;positive regulation of protein targeting to membrane;10.0;0.9326813400603323;0.8815816818910864;9.587702257971866;497.0805077511855;6.343086423195323;0.016636837251019197;0.7396267465268138;[, ITGAM, ITGB2, PDZK1, PAK1, FYN]
GO:0060305;regulation of cell diameter;6.0;1.0;0.8231203125901445;9.628524252492122;29.63014819255531;9.777073627680469;9.916943946027175E-4;0.8231203125901445;[PLEK]
GO:0061515;myeloid cell development;4.0;0.811012628672052;0.655506314336026;9.022388448921806;32.15320660831846;5.9928839937622085;0.001076138889173156;0.5564763661386056;[CSF3, ARID4A, GATA1, TNFSF11, TSPAN2, NCKAP1L, MED1, BPGM, MEIS1, BCL6, KIT, PTPN6, RHAG, EVI2B, TLR2]
GO:1904996;positive regulation of leukocyte adhesion to vascular endothelial cell;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;71.15170694072506;7.8311634786251565;0.002381383598927155;0.7514054297404357;[ITGA4, PTAFR, TNF, ETS1, ELANE, CCR2, ICAM1]
GO:2001190;positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell;9.0;1.0;0.896240625180289;9.628524252492122;413.7426732268016;9.083926447120524;0.013847594928669781;0.8607930461318132;[HLA-DMB]
GO:0048539;bone marrow development;5.0;1.0;0.7902410118609202;9.628524252492122;32.5184652959493;7.697632086000634;0.001088363768736683;0.6838982747154925;[PTPRC, HOXB4]
GO:0002576;platelet degranulation;8.0;1.0;0.875;9.628524252492122;39.85546922145481;4.956792062075433;0.0013339266872485146;0.6284905765689417;[ORM1, ECM1, SERPINA1, SPARC, PROS1, ITGB3, ITGA2B, SERPINE1, PLEK, F13A1, CTSW, CLU, LAMP2, TIMP3, CD36, TIMP1, VWF, ACTN1, APLP2, ANXA5, ACTN4, F5, MMRN1, PECAM1, SERPING1, TLN1, VCL, CFD, STXBP2, PDGFA, THBS1, PSAP, FLNA, A2M, LYN, TGFB2, TGFB1, EGF, PCDH7, FN1, LHFPL2, PPBP, SELP, TF, CD9, PF4]
GO:0048661;positive regulation of smooth muscle cell proliferation;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;63.45804869205661;5.433268205826786;0.002123883781187112;0.6009779013089371;[TNF, MYB, AKT1, SKP2, IL6R, PDGFRB, IL10, EDN1, IGFBP5, MMP2, IL18, MMP9, EREG, HBEGF, CALCRL, PTAFR, PTGS2, THBS1, AIF1, GNAI2, PAK1, CCL5, PDGFD, HMOX1, ELANE, JUN, IL6, NR4A3, NOX1]
GO:0050730;regulation of peptidyl-tyrosine phosphorylation;9.0;0.6873818243518346;0.7399315373562063;9.0689084645567;111.97076766282173;4.31748811353631;0.003747560826526104;0.6170371680902661;[CSF3, NCF1, CD80, ICAM1, PPP2R1A, IL6R, PRKCE, PRKCD, MIF, EREG, SFRP2, IL23A, CSF1R, TGFA, PDGFA, THY1, GATA1, PRKCZ, PDGFD, PDGFC, STAP1, LYN, TGFB1, ACE, CAV1, LIF, BST1, GH1, IL6, CSPG4, CD24, NRP1, CD40, ITGB3, IFNA2, ITGB2, TREM2, ARRB2, CD3E, GHR, GRM5, CD36, SYK, RIPK2, IL18, PARP9, GREM1, IFNG, BANK1, KIT, HBEGF, HDAC2, CCL5, NTF3, FYN, CD74, EGF, OSM, CD4, PTPN6]
GO:0007229;integrin-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;5.311165509025885;8.87013979980389E-4;0.5947335637161829;[NRP1, ITGAM, ITGB5, ITGB4, ITGB3, ITGA2B, ITGB2, PLEK, ITGAL, CTGF, ADAMTS1, ITGAX, ITGB8, ITGB7, ITGB6, FCER1G, SYK, ITGA4, VAV1, FGR, HCK, CEACAM1, TYROBP, ADAM9, ITGA7, TLN1, CDH17, TXK, THY1, PTK2, COL3A1, ZYX, PLP1, LAT]
GO:0006933;negative regulation of cell adhesion involved in substrate-bound cell migration;6.0;1.0;0.8231203125901445;9.628524252492122;40.059981433445344;8.67846133901236;0.0013407715269347963;0.7669372290569613;[PTPRC]
GO:0071673;positive regulation of smooth muscle cell chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;372.1937940336002;8.67846133901236;0.012456991333636938;0.8400575416471059;[PDGFD, AIF1]
GO:0071157;negative regulation of cell cycle arrest;7.0;1.0;0.8509193652572005;9.628524252492122;127.41368125290029;6.641579411751319;0.004264421246666119;0.6905700452391912;[MIF, EVI2B]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[AKT1, JUNB, PRKCD, FPR1, GATA3, FLRT2, HMOX1, HLA-DQA2, HLA-DQA1, HLA-DRB4, FN1, COL1A2, HLA-DRB1, CDKN1A, LRRC4, TIMP1, JAK3, HLA-DPA1, ANXA1, SERPINB2, IFNGR1, GPR35, RIPK2, IFNGR2, BGN, FOS, SIRT1, F3, FCER2, PLCB1, HLA-DQB1, CCL13, LRRC19, PTAFR, PTGS2, ALOX5, STAT4, CCL19, CCL18, IL12RB1, IL12RB2, CCL23, CCL21, CCL20, HLA-DPB1, PF4, CSF3, CSF3R, F13A1, IL5RA, RORA, CXCL13, TNF, PYCARD, IGHG1, IL13RA2, IL13RA1, IFNA14, CISH, IFNA16, IFNA10, CSF1R, TNFRSF11A, FOXO1, SOCS2, TNFRSF17, IFNA21, TNFRSF10C, TNFRSF10B, NFKB1, CXCL10, CXCL11, CXCL12, BCL6, LCN2, BCL2, HLA-DRA, MYD88, BCL2L1, CIITA, ITGAM, ITGB2, PIK3CD, FASLG, TNFSF13B, ITGAX, CHUK, TNFRSF1B, IL3RA, XCL2, XCL1, BIRC5, LCP1, BIRC2, BIRC3, CX3CR1, CEBPA, CEBPD, NOD2, IL2RG, CCL8, CCL7, CCL5, CCL4, IL21R, CCL2, CCL1, FYN, FCGR1A, FCGR1B, PML, KLF6, IL2RB, PTPN6, IL1RN, IFI30, IFIT1, IFIT3, IFIT2, ICAM1, TNFSF11, TRIM25, RSAD2, ACSL1, IL1R1, IL1R2, HLA-B, FLT3LG, HLA-C, MIF, HLA-A, HLA-F, HLA-G, EREG, HLA-E, IFI27, IL23A, TWIST1, INPP5D, CCR10, CCR1, EGR1, TNFSF14, TNFSF12, TNFSF13, LIF, PPBP, SDC1, CD27, IFNA5, IFNA4, IFNA7, CD40, TNFRSF13B, IFNA2, IFNA8, CCR9, CCR7, CCR6, CD36, CCR5, CCR2, IL10, SYK, IL18, GP1BA, GAB2, IL17RB, VAV1, HCK, IL1A, CEACAM1, IL1B, KIT, RHOU, SP100, CXCR5, IFI6, CXCR4, CXCR6, CXCR1, CXCR3, CXCR2, IL32, CD74, IL33, OSM, PODN, CD40LG, IL18R1, IL17A, CD86, CD80, MPL, IL18RAP, CCRL2, IL6R, PRTN3, CSF2RB, CSF2RA, TGFB1, VCAM1, ISG15, NFKBIA, IL6, IL7R, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, OASL, GHR, LRRTM4, MMP1, MMP2, IRAK3, MMP9, DCN, IFNG, OAS1, OAS3, LTA, IRF7, LTB, CAMK2D, SAMHD1, NCAM1, MX2, SOD2, CD4, LTBR]
GO:0048662;negative regulation of smooth muscle cell proliferation;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;63.58586787906956;5.970411137910149;0.0021281617743466354;0.6284474158353811;[CDKN1A, TNFAIP3, AIF1, CNN1, HMOX1, IL10, MEF2C, PTGIR, MYOCD, IGFBP5, IGFBP3, TPM1, KLF4, SOD2, IFNG, OGN, TRIB1]
GO:0051384;response to glucocorticoid;7.0;0.7671156992804218;0.7344772148974115;9.223059144383958;62.73690238121479;4.800339885259895;0.00209974766315278;0.5964089702280253;[CDKN1A, IL1RN, SPARC, ADM, TNF, AQP1, ICAM1, ALAD, IL10, GHSR, EDN1, ANXA1, DUSP1, ANXA3, ARG1, CAD, AVPR1A, FOS, ADCYAP1, IL1B, ADAM9, ACSBG1, PCNA, FECH, ABCB4, PTAFR, PTGS2, AIF1, FOXO1, IGFBP7, TGFB1, IL6, BCL2, ALPL, SDC1, FOSB]
GO:0071672;negative regulation of smooth muscle cell chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;373.36881743152423;8.390779266560578;0.012496318309313052;0.8253454670833372;[AIF1]
GO:0071315;cellular response to morphine;8.0;1.0;0.875;9.628524252492122;528.974071528598;8.390779266560578;0.017704286128305307;0.8041048419030481;[AIF1]
GO:0071312;cellular response to alkaloid;6.0;0.7866048967936545;0.7164227609869718;9.245532000236016;164.36700762083373;6.280566066213989;0.005501215824366272;0.6443087532925187;[BLM, ABCB4, AIF1, SLC8A1, ICAM1, CCNA2, RAD51, BCL2L1]
GO:0050857;positive regulation of antigen receptor-mediated signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.52844079393514;294.8408907598327;6.7325511899570465;0.00986805927415722;0.6952223462072524;[LYN, PRKCH, TRAT1, NFAM1, PTPRC, LCK, STAP1, CCR7]
GO:0010477;response to sulfur dioxide;4.0;0.9326813400603323;0.7163406700301662;9.446202695698167;26.645441185012544;9.777073627680469;8.917989371221739E-4;0.75;[ICAM1]
GO:0050731;positive regulation of peptidyl-tyrosine phosphorylation;10.0;0.7866048967936545;0.8085434602577476;9.446202695698167;779.3603785568229;4.60092389510664;0.02608449049149353;0.6505324738215158;[NRP1, CD40, CSF3, NCF1, CD80, ITGB3, IFNA2, TREM2, ARRB2, CD3E, ICAM1, GHR, GRM5, CD36, IL6R, SYK, RIPK2, IL18, MIF, PARP9, EREG, GREM1, IFNG, BANK1, IL23A, KIT, HBEGF, CSF1R, HDAC2, TGFA, GATA1, CCL5, NTF3, STAP1, FYN, LYN, CD74, TGFB1, ACE, EGF, LIF, OSM, GH1, CD4, IL6, CSPG4, CD24]
GO:0050852;T cell receptor signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;219.43154282413207;4.981283082083729;0.007344176262756358;0.6699840603320352;[DENND1B, ITK, TRAC, PIK3CD, CD3G, PTPN22, CD3E, CD3D, GRAP2, TRBC1, PDE4B, ICOSLG, HLA-DPA1, CHUK, RIPK2, THEMIS, LIME1, ZAP70, LCK, BTK, PRKCQ, LCP2, CARD11, HLA-DQB1, HHLA2, TXK, GATA3, THY1, PAK1, INPP5D, PLCG2, FYN, CSK, PLCG1, HLA-DQA2, HLA-DQA1, PAG1, BTNL8, EIF2B3, HLA-DRB4, TRAT1, BMX, NFKB1, CD4, PTPRC, CD28, HLA-DPB1, HLA-DRA, CD247, LAT, HLA-DRB1]
GO:0050853;B cell receptor signaling pathway;10.0;0.9326813400603323;0.8815816818910864;9.582004236857228;219.43154282413207;4.948759890378168;0.007344176262756358;0.6683208227957298;[, BLK, IGHM, ITK, TXK, PIK3CD, CD79B, CD79A, IGHG1, IGKC, CD19, TRBC1, PLCG2, CTLA4, CD38, NCKAP1L, IGHA1, LYN, MEF2C, SYK, BMX, LIME1, LAT2, PTPRC, LCK, BTK, IGHD, BCL2, PTPN6, MNDA]
GO:0046488;phosphatidylinositol metabolic process;7.0;0.6835726970475526;0.6927057137809769;8.801845679307654;147.2037350013595;4.383446081328108;0.004926776535734991;0.5750890017074093;[CD86, CD80, SLA2, FGF5, PDGFRB, PDGFRA, CISH, TTC7B, EREG, BTC, PLBD1, CSF1R, PDGFA, PIK3R3, PIK3R5, SOCS2, CD19, INPP5D, PLCG2, PIP5K1B, ICOS, BMX, CD28, PLEK, PIK3CD, PIK3C2A, IMPA2, GAB1, VAV1, LCK, KIT, PLCB1, HBEGF, FYN, TRAT1, EGF, MBOAT7, KITLG, PIKFYVE]
GO:0001541;ovarian follicle development;4.0;1.0;0.75;9.628524252492122;34.608406302298;6.166155715036245;0.001158312213394382;0.5653374900225189;[CEBPB, INHBA, FANCG, ICAM1, ADCYAP1, KIT, CTNNA1, BCL2, MMP19, BCL2L1]
GO:0001774;microglial cell activation;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;31.19674186509269;6.8867018697843045;0.001044126874979773;0.6753065664753021;[CX3CR1, IL33, JUN, ITGAM, ITGB2, FPR2, AZU1, CLU, AIF1, TLR8, TLR7, TLR6, TLR2, SNCA]
GO:1990830;cellular response to leukemia inhibitory factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[TFRC, ICAM1, TNFSF11, TRIM25, TLE4, PCOLCE, SIRT1, PADI2, LAPTM5, KLF4, PML, BSPRY, KLF5]
GO:0002503;peptide antigen assembly with MHC class II protein complex;7.0;1.0;0.8509193652572005;9.628524252492122;45.61567929762514;8.67846133901236;0.0015267157346454312;0.7947362817240173;[HLA-DMA, HLA-DMB, HLA-DRA]
GO:0010925;positive regulation of inositol-polyphosphate 5-phosphatase activity;10.0;1.0;0.9152410118609203;9.628524252492122;315.02421328910475;9.777073627680469;0.010543576915400974;0.9152410118609203;[PLEK]
GO:0001934;positive regulation of protein phosphorylation;9.0;0.5833093054345528;0.6878952778975655;8.604019935977734;663.1129447749842;2.9039097934679514;0.02219379349871355;0.5447467070638558;[, PHB2, AKT1, PROK2, PRKACB, PRKCE, PRKCD, PRKAR1B, FPR1, PDGFA, FPR2, SLC30A10, IQGAP3, GATA1, PRKCZ, C3, PRKAR2B, PDGFD, PDGFC, S100A12, NCKAP1L, ELANE, LYN, FZD1, JUN, ACE, FZD5, PLK1, FZD8, EIF2AK2, CDC6, AZU1, NOX4, NOX1, EZH2, CDKN1A, TIMP2, HAVCR2, GPR37, RIPK2, FCRL3, SIRT1, DUSP6, CKS2, PLCB1, HBEGF, ENG, CCL13, FAM129A, PTGS2, GPNMB, NTF3, CCL19, CCL18, CCL23, CCL21, CCL20, CARD9, CENPE, PKN1, CSF3, CCNT2, NCF1, FMR1, TNF, CLU, CTGF, PYCARD, IFNA14, MAP2K2, IFNA16, IGFBP3, F2R, ADCYAP1, ADAM9, ADAM8, IFNA10, CSF1R, TNFRSF11A, PSAP, DRD4, IFNA21, MAP2K6, TNFRSF10B, DAB2, PTPRC, CDK1, BCL2, CSPG4, LAT, LRRK2, ITGB3, TREM2, PTPN22, ARRB1, ARRB2, CYR61, XCL2, XCL1, LCP2, HDAC2, NOD2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, CSK, TIE1, RAD50, FCGR2B, IL1RN, CCNH, CCNC, ICAM1, TCL1A, EDNRB, TNFSF11, EPHB2, EPHB1, ACSL1, SLC11A1, FLT3LG, MIF, EREG, SFRP2, IL23A, EPHA3, EPHA2, TGFA, PIK3R5, SLAMF1, CCR1, EGR1, LIF, PTK2, MARCO, CD27, CALM3, CD24, IFNA5, IFNA4, NRP1, IFNA7, CD40, IFNA2, CD3E, IFNA8, CCR7, CD36, MAP4K1, EDN1, SYK, STRADB, IL18, PARP9, MDFIC, BANK1, IL1B, KIT, TLR6, TLR4, CXCR4, AIF1, GNAI2, PAK1, CD74, OSM, CD40LG, CAMK1, CD80, IL6R, PDGFRB, PDGFRA, CALCA, C5AR1, ADRB2, RASGRP1, CCNB1, STAP1, ECT2, TGFB2, TGFB1, CAV2, CAV1, INHBA, GH1, IL6, BMP2, GHR, GRM5, PLAUR, AXIN2, MMP9, GREM1, PSRC1, IFNG, CHI3L1, PDE5A, LTF, THBS1, SNCA, EGF, MAPK14, CD4, LTBR, TEK]
GO:0002506;polysaccharide assembly with MHC class II protein complex;6.0;1.0;0.8231203125901445;9.628524252492122;58.63041707748974;9.083926447120524;0.0019623072956339374;0.7876727335416686;[HLA-DRA, HLA-DRB1]
GO:0030593;neutrophil chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;130.2972973825895;5.382624473008031;0.004360933283440787;0.671508291047556;[CXCL6, CCL13, CXCL9, IL1RN, CSF3R, C5AR1, ITGB2, PIK3CD, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, LGALS3, CCL8, CXCR1, CCL7, CCL5, CXCR2, CCL4, PDE4B, CCL2, S100A12, CCL1, NCKAP1L, CCL19, CCL18, CCL23, TGFB2, CXADR, FCER1G, SYK, CCL21, CCL20, PPBP, VAV1, CXCL10, CXCL11, IL1B, XCL2, XCL1, S100A9, S100A8, PF4]
GO:0010920;negative regulation of inositol phosphate biosynthetic process;8.0;0.9326813400603323;0.8413406700301662;9.59462270081644;802.7961320943956;9.777073627680469;0.026868864071587235;0.875;[PLEK]
GO:0033625;positive regulation of integrin activation;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;140.3817219977405;8.16763571524637;0.004698449899916962;0.7686126355688037;[PLEK, CXCL13, CDH17]
GO:0071549;cellular response to dexamethasone stimulus;9.0;1.0;0.896240625180289;9.628524252492122;704.2721689024621;6.343086423195323;0.023571355689363423;0.7206263598461826;[TGFB1, FECH, ARG1, ABCB4, FOXO1, AQP1, ICAM1]
GO:0032930;positive regulation of superoxide anion generation;8.0;1.0;0.875;9.628524252492122;144.57516735605006;7.004484905440688;0.00483880074220378;0.7332096838060964;[TGFB1, ITGAM, PRKCD, ITGB2, FPR2, GNAI2, CD177]
GO:0016601;Rac protein signal transduction;8.0;1.0;0.875;9.628524252492122;29.60642063139588;6.7325511899570465;9.9090025448413E-4;0.719302980950052;[CYFIP1, HACE1, RHOG, AIF1, EPS8, RAC2, RHOU]
GO:0070528;protein kinase C signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;7.212124270218933;8.845336528452411E-4;0.6919486831672181;[PRKCH, PLEK, AZU1, PRKCZ]
GO:0045963;negative regulation of dopamine metabolic process;8.0;0.9326813400603323;0.8413406700301662;9.574457031221845;288.50442548003474;8.390779266560578;0.0096559834836909;0.8041048419030481;[ITGAM, ITGB2, SNCA]
GO:0043542;endothelial cell migration;7.0;0.7980440201809971;0.7499413753476991;9.143016436710422;24.971868181253015;5.71663061713405;8.357859548042604E-4;0.6432681208679463;[NRP1, PLXND1, ITGB2, CXCL13, LOXL2, DPP4, CYP1B1, PRSS3, EGR3, TNFSF12, PTK2, GREM1, NR4A1, FAP, ID1, S100P]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[F11R, ICAM1, TIAM2, DEPDC1B, RIN2, LLGL2, EPHA2, THY1, RACGAP1, NCKAP1L, A2M, JUN, EZH2, ARHGAP9, DENND1B, NRP1, CD40, ARHGAP6, ARHGAP4, CCR7, RHOG, GMIP, VAV1, DEPDC1, PLCB1, CCL13, NTF3, CCL19, CCL18, RANBP2, RANBP1, CCL23, CCL21, CCL20, DLC1, SIPA1, CXCL13, RGS1, ARHGDIA, ARHGDIB, F2R, TSC2, ADCYAP1, ACAP1, PRTN3, ARHGAP19, ARHGAP15, RASGRP1, ADAP2, ECT2, EVI5, CAV2, ARHGAP25, TBCK, ARHGAP30, GNAQ, ARHGAP11A, DOCK4, LRRK2, ARRB1, TAGAP, ARHGEF12, TBC1D9, ARAP3, ARAP1, AXIN2, ALDH1A1, XCL2, XCL1, ASAP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1]
GO:0030866;cortical actin cytoskeleton organization;6.0;0.7671156992804218;0.7066781622303554;9.117698628726131;53.946853691669205;6.088194173566533;0.0018055526440439148;0.63447084575632;[PLEK, TNF, RACGAP1, EPB41L3, NCKAP1L, PLS1, VIL1, TLN1, LLGL2]
GO:0002438;acute inflammatory response to antigenic stimulus;6.0;0.7671156992804218;0.7066781622303554;9.117698628726131;43.66651068845287;7.57984905034425;0.0014614788154342952;0.710754145523778;[CD6, CXCR2, GATA3, ELANE, ICAM1]
GO:0071333;cellular response to glucose stimulus;8.0;1.0;0.875;9.628524252492122;272.3004295980195;5.69953618377475;0.009113650324169357;0.6664745454937787;[ICAM1, LGALS1, SOX4, MEN1, PAX2, NME1, LIN28A, IL1B, NOX4]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[PRF1, ADARB1, IFIT1, IFIT3, IFIT2, PYCARD, HERC5, DHX58, TRIM25, IFNA14, RSAD2, IFNA16, RNASE6, RNASE2, IL23A, IFNA10, DDX60, NLRP3, IFNA21, EIF2AK2, ISG15, AZU1, DEFA1, CXCL10, IL6, PTPRC, BCL2, SERINC5, APOBEC3A, IFNA5, IFNA4, IFNA7, CXCL9, CD40, IFNA2, IFNA8, OASL, IFIH1, DDX58, PARP9, PLSCR1, IFNG, OAS1, OAS3, IRF7, TLR8, TLR7, ZMYND11, EXOC1, UNC93B1, SAMHD1, IL33, MX2, CARD9, LILRB1, PML]
GO:0071456;cellular response to hypoxia;6.0;1.0;0.8231203125901445;9.628524252492122;103.24589989147204;5.104244793218563;0.0034555473540902374;0.5841516286869992;[SUV39H1, MPL, RORA, PHB2, SLC8A1, AQP1, ICAM1, AKT1, EDN1, KCND2, PRKCE, SIRT1, CCNA2, ADAM8, TWIST1, PTGS2, CCNB1, E2F1, HMOX1, FABP1, BCL2]
GO:0051209;release of sequestered calcium ion into cytosol;14.0;0.7980440201809971;0.874941375347699;9.527428135620752;522.9340415463636;5.9928839937622085;0.01750213176047399;0.7823957313958061;[CCL21, PRKCE, F2R, FASLG, ITPR3, JPH2, PTPRC, LCK, FKBP1B, PLCG2, XCL1, CCR7, CCL19, CCR5]
GO:0090026;positive regulation of monocyte chemotaxis;10.0;1.0;0.9152410118609203;9.628524252492122;859.35541097108;6.8867018697843045;0.028761852235543582;0.7674272657460779;[CCR1, CXCL10, CXCL12, CCL5, SERPINE1, CCL1, FPR2, S100A14, PLA2G7, AIF1, CCR2]
GO:0002291;T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell;7.0;1.0;0.8509193652572005;9.628524252492122;83.84221930200768;8.67846133901236;0.002806123626939655;0.7947362817240173;[ITGAL, ICAM1]
GO:0034142;toll-like receptor 4 signaling pathway;12.0;0.8436909121759173;0.8699657686781033;9.485423408851448;412.6549923027037;6.943860283624253;0.013811191226989502;0.8032296504172152;[ITGAM, RIPK2, PRKCE, ITGB2, NR1H4, LY96, NFKBIA, S100A14, CD14, TLR4]
GO:0042100;B cell proliferation;6.0;0.8653626801206646;0.7558016526504768;9.387362195675234;50.60132884827668;6.166155715036245;0.00169358093831245;0.6384578026126634;[IFNA5, IL10, IFNA4, IFNA7, MEF2C, CR2, CD40, IFNA14, IFNA16, IFNA2, CD180, PRKCD, LEF1, IFNA8, HSPD1, CD79A, CD40LG, PTPRC, BCL2, IL7R, MS4A1, CARD11, IFNA21, IFNA10]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[CDA, CYFIP1, ABCA13, PSMD3, C3AR1, PRSS3, PRKCD, RNASE3, RNASE2, BIN2, PADI2, CFD, FPR1, FPR2, CFP, GNS, C3, S100A12, NCKAP1L, ELANE, S100A11, JUP, FUCA1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, TIMP2, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, GRN, PTAFR, ALOX5, METTL7A, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, ATP8A1, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, RAB31, ADAM8, SLC27A2, S100A9, S100A8, BRI3, HVCN1, GPR84, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, HPSE, ITGAM, ITGB2, ITGAL, FCAR, ALAD, FCGR3B, GM2A, ITGAX, DSP, CR1, NDUFC2, TNFRSF1B, PECAM1, BPI, ACPP, FGL2, TTR, CPPED1, FCGR2A, P2RX1, IMPDH2, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, CD14, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSZ, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CAMP, CD33, CTSB, CD53, CCT2, FCER1G, MME, RHOG, CEACAM1, CEACAM6, CEACAM8, TLR2, LILRA3, CST3, CXCR1, CXCR2, CD58, CCT8, GCA, LILRB2, LILRB3, QPCT, CD68, FCN1, MPO, PLAU, SIRPA, CD97, CHRNB4, CD93, CYBB, OSCAR, DOK3, TYROBP, PRTN3, VCL, PSMD14, C5AR1, MGAM, HSPA6, SELL, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, PLAUR, MMP8, MMP9, FGR, CHI3L1, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:0042102;positive regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;564.8543510249671;5.212725436212633;0.018905166792893686;0.6628196464047262;[CD86, TFRC, CD80, CD3E, TNFSF13B, PYCARD, IL6R, JAK3, ICOSLG, CCR2, HLA-DPA1, HAVCR2, ANXA1, SYK, RIPK2, IL18, PDCD1LG2, HLA-E, ZAP70, IL23A, IL1B, XCL1, PRKCQ, CARD11, CD274, BLM, HHLA2, CD1D, CORO1A, AIF1, HLA-DMB, CCL5, NCKAP1L, CCL19, IL12RB1, VCAM1, LILRB2, CD4, IL6, CD40LG, PTPRC, CD6, DNAJA3, CD28, HLA-DPB1, CD24]
GO:0002693;positive regulation of cellular extravasation;9.0;0.7866048967936545;0.7895430735771163;9.36615998802463;295.62290900694154;7.138016298065211;0.009894232721117224;0.7612791106150483;[IL1A, ITGA4, IL1R1, PDGFD, PTAFR, ADAM8, THY1, ELANE, CCR2, ICAM1]
GO:0043315;positive regulation of neutrophil degranulation;11.0;1.0;0.9324289523296623;9.628524252492122;798.7725987099202;8.390779266560578;0.0267342000301538;0.8615337942327104;[ITGAM, PTAFR, ITGB2, CD177]
GO:0030217;T cell differentiation;6.0;0.657518819034173;0.651879722107231;8.679443697794976;65.04859315339479;5.132682728539097;0.00217711787291102;0.5856059460217904;[ITK, PIK3CD, CD3G, PTPN22, RORA, CD3E, CD3D, CCR9, CCR6, SOX4, EOMES, ANXA1, FCER1G, RSAD2, RHOH, RUNX2, VAV1, ZAP70, CLEC4D, LCK, CD8A, KIT, CLEC4E, BLM, TXK, LEF1, TCF7, GATA3, TBX21, NKX2-3, EGR1, TGFB1, BCL11B, FZD5, FZD8, BMX, CD4, PTPRC, MAFB, DNAJA3, BCL3, CD28, BCL2, IL7R, GPR18, IL18R1]
GO:0010629;negative regulation of gene expression;6.0;0.471430776349301;0.558835700764795;6.738152494595957;59.04642522059629;2.349334787147576;0.001976230713800692;0.44326540286011196;[SPI1, EHMT2, SLA2, AKT1, MEF2A, MEF2C, ATF3, GATA3, IQGAP3, GATA1, HESX1, JUN, EIF2AK2, NR2F2, PKIG, EZH2, SIRT1, SRP9, MMP12, BTAF1, FLNA, CENPF, LGR4, GMNN, CTGF, FOXO1, ZNF423, NFKB1, NFKB2, CIITA, LRRK2, FHL2, PIK3CD, FASLG, HHEX, ITGB8, PEG3, BIRC5, BIRC2, BIRC3, E2F1, FYN, E2F7, PRRX1, EIF3E, IKZF1, UXT, HNF1B, MIF, EREG, SFRP2, IFI27, KCNQ1, NAIP, GSPT1, PCBP3, A2M, CCR1, EGR1, MSR1, ID1, CD28, SUV39H1, CTSZ, PTPRK, BRCA1, CD3E, BMI1, CD38, CD36, CD34, BANK1, IL1B, DEPDC1, SATB2, RXRA, NEDD4, LOXL2, EOMES, CCNE1, CALCA, TCF7, CCNB1, VDR, CAV1, HMGA1, BMP2, UBA3, MXD1, HMGB2, MYOCD, GREM1, ELF3, IRF7, FBP1, AURKB, TBX21, SERPINE1, PHB2, MYB, HOXA2, HOXA7, JUNB, MED1, DAPK1, HOXB4, HOXB3, SERPING1, PRDM16, ELANE, BARD1, FZD1, NDFIP2, PLK1, FZD8, UPF3B, SNAI2, CDKN1A, BTG2, HAVCR2, PAWR, PAX5, PAX2, AES, RARA, GAS1, PLCB1, ENG, NR1I2, ASCL2, NR1H2, NR1H4, POU4F1, FOSB, FMR1, TNF, DACH1, MEN1, TLE4, MAP2K2, IGFBP5, AEBP1, NACC2, WFS1, LSM5, LSM3, DAB2, BCL6, CNOT3, BCL3, PTPN22, EMILIN1, CR1, RFC1, PTBP2, XCL1, CEBPA, CEBPB, HDAC2, NLRC4, RBBP8, ZNF503, KLF4, PML, KLF8, KLF5, DNAJA3, GFI1, ZNF608, EDNRB, PPP2R1A, MAGOH, DPF3, SOX7, SOX4, IL1R2, RUNX2, TWIST1, BCL11A, IFNA2, XPO1, EDN1, PARP9, CBFA2T3, NME1, MDFIC, SP100, AIF1, PURA, CDX2, MLH1, ARID4A, CHCHD3, BASP1, TGFB2, TGFB1, CBX4, EIF2S1, NR4A2, LIN28A, NR4A3, CREBZF, KLF12, H2AFX, IFNG, PFDN5, LEF1, THBS1, SNCA, MEIS2, RBMX]
GO:0031668;cellular response to extracellular stimulus;4.0;0.5452700253111464;0.5226350126555732;7.377232453885626;45.163559484697416;4.334655917158676;0.0015115836913881548;0.47167450518560927;[EHMT2, TNC, ICAM1, SESN3, LAMP2, SKP2, POSTN, CYBB, SFRP2, RRAGD, SIK1, ATF3, SEH1L, ABCB4, FOXO1, HMOX1, GAS2L1, LYN, JUN, EIF2AK2, EIF2S1, NR4A2, COL1A1, BCL2, CDKN1A, PLEKHF1, LRRK2, KRT20, ASGR1, UPP1, AVPR1A, FOS, SIRT1, AES, PTGS2, AIF1, FYN, NR1H4, SIPA1, FOXA3, FOXA2]
GO:0097178;ruffle assembly;6.0;1.0;0.8231203125901445;9.628524252492122;77.5241744012752;7.379178354882098;0.0025946643499833917;0.7004918368257019;[AIF1]
GO:0031669;cellular response to nutrient levels;5.0;0.5537205960740763;0.5671013098979585;7.6544432264701125;58.45336087306237;4.4540636485420615;0.0019563813838119923;0.5180220339825032;[EHMT2, TNC, ICAM1, SESN3, LAMP2, POSTN, CYBB, RRAGD, SIK1, ATF3, SEH1L, ABCB4, FOXO1, HMOX1, GAS2L1, JUN, EIF2AK2, EIF2S1, COL1A1, BCL2, CDKN1A, PLEKHF1, LRRK2, KRT20, UPP1, SIRT1, PTGS2, FYN, NR1H4, FOXA3, FOXA2]
GO:0045860;positive regulation of protein kinase activity;10.0;0.6281612110245125;0.7293216173731766;9.003430535177193;1094.9224192180604;3.5309668621989068;0.03664606800502658;0.5958148214005239;[, IL1RN, CCNH, CCNC, TCL1A, AKT1, PROK2, TNFSF11, PRKACB, ACSL1, SLC11A1, PRKCD, MIF, EREG, PRKAR1B, IL23A, FPR1, TGFA, PDGFA, IQGAP3, PRKCZ, PIK3R5, PRKAR2B, PDGFD, PDGFC, S100A12, NCKAP1L, ELANE, EGR1, ACE, FZD5, FZD8, EIF2AK2, CDC6, AZU1, PTK2, NOX4, CALM3, CD24, EZH2, CDKN1A, CD40, CCR7, MAP4K1, EDN1, SYK, RIPK2, STRADB, IL18, SIRT1, DUSP6, MDFIC, IL1B, KIT, CKS2, TLR6, TLR4, CXCR4, PAK1, NTF3, CCL19, CD74, CCL21, CENPE, CD40LG, PKN1, CAMK1, CCNT2, NCF1, TNF, CLU, IL6R, PDGFRB, MAP2K2, F2R, ADCYAP1, ADAM9, ADAM8, CSF1R, CALCA, C5AR1, TNFRSF11A, ADRB2, RASGRP1, CCNB1, STAP1, ECT2, DRD4, MAP2K6, TGFB2, TGFB1, TNFRSF10B, GH1, BMP2, PTPRC, CDK1, CSPG4, LAT, LRRK2, ITGB3, ARRB1, CYR61, GHR, GRM5, GREM1, PSRC1, IFNG, CHI3L1, LCP2, PDE5A, LTF, NOD2, THBS1, CCL5, FYN, CSK, SNCA, EGF, MAPK14, CD4]
GO:0035987;endodermal cell differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;6.444869117505266;7.050676185779127E-4;0.5795909063862833;[LAMB3, ITGB5, ITGA4, COL11A1, MMP2, LAMA3, COL12A1, ITGB2, FN1, LAMB1, INHBA, MMP8, MMP9, COL4A2, COL6A1, COL8A1, ITGA7]
GO:0071447;cellular response to hydroperoxide;5.0;0.8653626801206646;0.7229223519212526;9.485423408851448;143.11325921270426;7.697632086000634;0.004789871992277907;0.6838982747154925;[DAPK1, PRKCD, MGST1, CD36, AIF1]
GO:0032870;cellular response to hormone stimulus;5.0;0.6039883530135606;0.5922351883677006;7.932074963068391;80.94247679971589;3.9540277321974506;0.0027090718549867714;0.49245017396659174;[CYFIP1, PID1, TNC, AQP1, ICAM1, RUVBL2, AKT1, PRKACB, JUNB, PTGDR, MEN1, GHSR, MED1, LHCGR, MEF2C, PRKCE, PRKCD, LMO2, ADCYAP1, POR, ADCY9, RAB31, PRKAR1B, SIK1, FECH, ABCB4, SLC30A10, GATA1, FOXO1, SOCS2, PRKAR2B, IGFBP7, GAS2L1, JUN, TGFB1, CAV1, CDC6, INHBA, NFKB1, NR4A2, NR4A1, KIF18A, NR4A3, FBN1, ROBO2, CTSS, GHR, CTSH, CTSB, IL10, EDN1, ANXA1, DUSP1, ARG1, GLP2R, AVPR1A, FOS, CCNA2, CEACAM1, KIT, PTGER2, AIF1, P2RY6, PAK1, SPP1, FYN, CSK, SORBS1, POU4F1, TSHR, FOSB, RAMP1]
GO:0001915;negative regulation of T cell mediated cytotoxicity;9.0;0.8933024483968273;0.8428918493787028;9.557065288509976;365.562885098783;7.9853141584524145;0.012235060779019208;0.8046099625986299;[CEACAM1, PTPRC, LILRB1, FCGR2B, IL7R]
GO:0032233;positive regulation of actin filament bundle assembly;10.0;0.8933024483968273;0.861892236059334;9.533214072687796;256.92976895603965;5.734022359845919;0.008599208145178776;0.7084791820027498;[NRP1, SYNPO2, PLEK, ARHGEF10L, CTGF, PAK1, FLNA, TPM1, VIL1, ID1, NOX4, PFN1]
GO:0008360;regulation of cell shape;6.0;0.6763753087927167;0.6613079669865028;8.690254613899192;41.77565885716001;4.6590798152637145;0.0013981937062970905;0.5613858710120996;[CYFIP1, PLXND1, LST1, ICAM1, EPS8, TPM1, VRK1, CSF1R, EPB42, ARHGAP15, CORO1A, SPTA1, EPB41L3, MYH14, MYH10, FN1, PARVB, PTK2, VIL1, FES, PLXNB2, ITGB2, ANXA1, RHOG, ARAP3, RHOH, ARAP1, FGR, HCK, KIT, ITGA7, RHOU, CCL13, FGD3, FGD4, CCL7, PDPN, CCL2, FYN, WASF3, DLC1]
GO:0046718;viral entry into host cell;7.0;0.7671156992804218;0.7344772148974115;8.935377071932177;28.374411874040543;5.346256828837156;9.496660301113433E-4;0.6243271881103005;[SCARB2, CD86, TFRC, ITGB5, CD80, ITGB3, F11R, ICAM1, ANPEP, CLEC5A, ITGB7, ITGB6, HAVCR1, CTSB, CR2, CR1, CXADR, EPHA2, GYPA, DPP4, NCAM1, SLAMF1, GPR15, CDK1]
GO:1903980;positive regulation of microglial cell activation;8.0;1.0;0.875;9.628524252492122;155.50143499853152;7.697632086000634;0.005204493087195169;0.7686572628545723;[ITGAM, LRRK2, ITGB2, STAP1]
GO:0045907;positive regulation of vasoconstriction;8.0;0.8933024483968273;0.8216512241984136;9.57973408832269;103.52331479149503;6.280566066213989;0.003464832181136806;0.6961884407023742;[CAV1, PTAFR, F2R, AVPR1A, PTGS2, ICAM1, AKT1, CD38]
GO:0043200;response to amino acid;5.0;0.6441938053840475;0.612337914552944;8.412128928167629;56.712201515420396;5.104244793218563;0.0018981063470534028;0.5512723279577749;[TNF, CTGF, ICAM1, ALAD, SESN3, PDGFRA, EDN1, CHUK, ARG1, MMP2, CYBB, COL4A1, COL6A1, RRAGD, NAIP, CEBPB, PCNA, ABCB4, PDGFD, PDGFC, FYN, LYN, COL1A1, COL3A1, COL1A2, COL5A2, BCL2L1]
GO:0006469;negative regulation of protein kinase activity;10.0;0.6835726970475526;0.7570273603846966;9.223059144383958;1097.0598301796;4.243684138952949;0.03671760522636433;0.6322632160784685;[ADARB1, PYCARD, PPP2R1A, AKT1, EPHB2, MEN1, CISH, PAQR3, PRKCD, TSC2, SFRP2, PRKAR1B, TRIB1, THY1, SOCS2, FLRT2, PRKAR2B, SFN, LYN, CAV1, PLK1, NR2F2, PTPRC, GNAQ, PKIG, CDKN1A, LRRC4, TNFAIP3, PTPN22, HHEX, DUSP10, LRRTM4, NUP62, DUSP2, MYOCD, DUSP3, DUSP1, BGN, IRAK3, GP1BA, SIRT1, DUSP6, DCN, CEACAM1, IL1B, CEBPA, LRRC19, CDKN2C, PODN, PTPN6, PKN1]
GO:0045744;negative regulation of G-protein coupled receptor protein signaling pathway;7.0;0.6467165523344657;0.6742776414244334;8.623002386890024;189.85671913105512;6.166155715036245;0.006354333529362364;0.6662568552797195;[, PLEK, ADRB2, ARRB2, GNAI2, CCL5, STMN1, SNCA]
GO:0001960;negative regulation of cytokine-mediated signaling pathway;7.0;0.7140352122741334;0.7079369713942671;8.965230035081857;244.80256319284138;5.8067817141283475;0.008193321482061134;0.6478784521606894;[ECM1, IL1RN, CCL5, STAP1, ARG1, NR1H2, IL1R2, CAV1, NR1H4, IRAK3, MMP12, IL6, PTPRC, PXDN, PADI2]
GO:0002378;immunoglobulin biosynthetic process;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;39.16312370347755;9.083926447120524;0.0013107545058323288;0.7547934328124444;[PTPRC]
GO:0045471;response to ethanol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;69.73224034292265;5.006389003214805;0.0023338753293357085;0.5462679783062231;[CSF3, SPI1, SPARC, TNC, ICAM1, EEF1B2, ALAD, PRKCE, CYBB, ADCYAP1, CLDN3, IL1B, CLDN7, RARA, S100A8, BIRC2, PSMD14, FECH, GATA3, CCL7, CNR1, FYN, CD14, GSN, VCAM1, CDK1, CD27]
GO:0030845;phospholipase C-inhibiting G-protein coupled receptor signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.976932752798508;9.777073627680469;9.028936615729279E-4;0.8231203125901445;[PLEK]
GO:0032868;response to insulin;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;74.03337757263446;4.800339885259895;0.0024778305216419678;0.5964089702280253;[CYFIP1, ADM, ICAM1, SESN3, AKT1, IL10, GHSR, CAD, SIRT1, CEACAM1, RAB31, TLR2, RETN, FOXO1, PAK1, PLN, LYN, EGR1, EGR2, SORT1, SORBS1]
GO:0071354;cellular response to interleukin-6;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;7.004484905440688;0.0027327542132076126;0.6813299963962409;[PID1, ST3GAL6, NFKB1, ICAM1]
GO:0072683;T cell extravasation;8.0;0.811012628672052;0.780506314336026;9.318369324188282;62.368388854006966;9.083926447120524;0.002087413847037777;0.839552420951524;[CCL2, ICAM1]
GO:0071356;cellular response to tumor necrosis factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;4.973052582947213;0.0027327542132076126;0.5774424529526606;[PID1, ZFAND6, RORA, BRCA1, ICAM1, PYCARD, TCL1A, AKT1, EDN1, POSTN, CHUK, SIRT1, XCL2, CHI3L1, XCL1, CCL13, CEBPA, CALCA, GATA3, ADAMTS12, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, CCL23, VCAM1, CCL21, CCL20, MAPK14, NFKB1, COL1A1]
GO:0035335;peptidyl-tyrosine dephosphorylation;8.0;0.8933024483968273;0.8216512241984136;9.52844079393514;179.24922260518233;5.181953777545879;0.005999310166768488;0.6400053571691908;[PTPRR, PTPN22, PTPRK, DUSP10, DUSP2, DUSP3, DUSP1, DUSP6, CDC25A, TPTE, PTPRE, PTPRC, PTPN6, PTPN7, PTPN4]
GO:0031532;actin cytoskeleton reorganization;6.0;1.0;0.8231203125901445;9.628524252492122;32.01253927882412;5.788089581116195;0.001071430880247358;0.6191234829421188;[NRP1, PLEK, ANTXR1, PRKCZ, PAK1, FLNA, CXADR, ANXA1, GAB1, PARVB, KIT, S100A9]
GO:0050776;regulation of immune response;4.0;0.37937792944451876;0.4396889647222594;5.635843344046521;22.446924158408432;2.846578861728843;7.512783506617425E-4;0.39557417536826767;[, CYFIP1, TFRC, CLEC10A, SLA2, MYB, TRBC1, C3AR1, UBASH3A, PRKACB, MED1, MEF2C, CXADR, PRKCH, PRKCE, PRKCD, SERPING1, PRKCQ, CFB, CFD, CFH, HHLA2, CFI, FPR1, FPR3, FPR2, GATA3, THY1, CFP, PRKCZ, C2, C3, KLRK1, C7, PLCG2, HMOX1, NCKAP1L, S100A14, PLCG1, IGHA1, HLA-DQA2, HLA-DQA1, ELANE, LYN, JUN, HLA-DRB4, FZD5, KIR2DS1, KIR2DS2, COL1A1, COL1A2, HLA-DRB1, DENND1B, ITK, SIGLEC9, IFIH1, CTLA4, JAK3, HLA-DPA1, HAVCR2, ANXA1, DUSP3, ARG1, IFNGR1, RIPK2, FCRL3, NFAM1, IFNGR2, PAWR, SERPINB9, PAX5, FOS, SIRT1, MMP12, FCER2, PLSCR1, RARA, TLR10, HLA-DQB1, PTAFR, UNG, HLA-DMB, CCL19, IL12RB1, NR1H2, CARD9, NR1H4, KIR3DL1, COL3A1, HLA-DPB1, PKN1, CLC, SIGLEC7, LGR4, PROS1, CXCL13, TNF, CLU, PYCARD, IGHG1, FCGRT, GRAP2, IL13RA2, CD177, LAG3, CD180, MSH6, CLEC4A, ADCYAP1, CLEC4D, MSH2, ADAM8, CLEC4E, S100A9, S100A8, BLK, CD274, LY96, CLEC7A, IGLV1-44, MAP2K6, EIF2B3, BMX, NFKB1, PTPRC, BCL6, BCL2, HLA-DRA, LAT, MYD88, ITGAM, ITGB2, PIK3CD, TREM2, PTPN22, ARRB2, ITGAL, TREM1, TNFSF13B, FCGR3A, DUSP10, ITGB7, CR2, CR1, CHUK, ITGA4, PVRIG, LCK, XCL1, LCP2, BIRC2, BIRC3, C1S, UNC93B1, C1R, NLRC3, NLRC4, NOD2, CCL5, FYN, CSK, FCGR1A, FCGR1B, FCGR2A, PTPN6, MNDA, CD247, FCGR2B, CLEC2D, GFI1, ICAM2, ICAM3, ICAM1, LGALS3, DHX58, ICOSLG, RSAD2, SLC11A1, HLA-B, HLA-C, MIF, HLA-A, HLA-F, HLA-G, EREG, HLA-E, IL23A, BTK, TXK, STXBP2, CD1E, CD1D, CD1C, CD1B, CD1A, CD79B, CD79A, CD19, INPP5D, SLAMF7, CD14, A2M, PAG1, SH2D1A, TNFSF13, PILRA, PTK2, MARCO, CD28, CD24, CD200, IGHM, ECM1, CD40, IFNA2, CD3G, CD3E, CD3D, CTSS, RAC2, FCER1A, CTSH, MUC13, CD38, FFAR2, CTSG, CCR7, MUC15, CD36, CD34, CD33, CCR2, IL10, FCER1G, SYK, IL18, GAB2, PARP9, LIME1, VAV1, LAT2, TLR1, NCR1, HCK, CEACAM1, IL1B, KIT, IGHD, TLR8, TLR7, TLR6, TLR5, TLR4, TLR2, C1QB, C1QA, LILRA1, LILRA2, PAK1, IGKC, NPDC1, CD74, IL33, LILRB1, LILRB2, MLH1, CD40LG, C1QC, CD86, FCN1, CD80, TRAC, IL18RAP, IL6R, CD96, THEMIS, MUC3B, OSCAR, TYROBP, CD8B, CD8A, KLRF1, CD300C, CARD11, KLRB1, C5AR1, KIR2DL1, KIR2DL2, CACNA1F, DDX60, KIR2DL3, RASGRP1, KIR2DL4, STAP1, NLRP3, LPXN, KLRC1, BTNL8, TGFB2, TGFB1, VCAM1, CAV1, CRTAM, NFKBIA, IL6, NR4A3, SELL, FES, KLRD1, IL7R, IGKV3-20, HMGB2, TNFAIP3, PDE4B, DDX58, MMP2, IRAK3, FGR, ZAP70, IFNG, LTA, IRF7, LTF, COLEC12, CLEC12B, SAMHD1, HSPD1, CNR1, HLX, TBX21, TRAT1, MAPK14, CD4]
GO:0010572;positive regulation of platelet activation;9.0;0.8933024483968273;0.8428918493787028;9.592156608321247;334.5200598726648;8.16763571524637;0.011196085355429928;0.8139338954918922;[SELP, PDPN, PLEK, TLR4]
GO:0060333;interferon-gamma-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.514393750639154;0.00101047745553359;0.6329257181104212;[CIITA, IFI30, OASL, ICAM1, TRIM25, HLA-DPA1, IFNGR1, IFNGR2, PRKCD, HLA-B, HLA-C, HLA-A, HLA-F, HLA-G, HLA-E, HCK, IFNG, OAS1, OAS3, IRF7, HLA-DQB1, CAMK2D, SP100, PTAFR, NCAM1, FCGR1A, FCGR1B, HLA-DQA2, HLA-DQA1, HLA-DRB4, VCAM1, PML, HLA-DPB1, HLA-DRA, HLA-DRB1]
GO:1900087;positive regulation of G1/S transition of mitotic cell cycle;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;354.40743100732976;6.409777797693995;0.011861697769835146;0.7240369598395108;[ANXA1, KCNA5, CDC6, AIF1, PLCB1]
GO:0030041;actin filament polymerization;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;66.55674193746657;6.409777797693995;0.0022275942554681166;0.6787156999164222;[GSN, ARHGAP6, AIF1, VIL1, WASF3]
GO:0007166;cell surface receptor signaling pathway;5.0;0.43360584258713153;0.507043933154486;5.906854975555195;23.17027026302992;2.006850423521684;7.75488093814194E-4;0.39287143584790796;[, SLA2, F11R, TRBC1, C3AR1, AKT1, PRKACB, WLS, MEF2C, ZFYVE16, HHLA2, FPR1, PDGFA, FPR3, FPR2, GATA3, THY1, SLC30A10, KLRK1, PDGFD, PDGFC, LYN, ABCA1, JUN, JAG1, HLA-DRB4, FN1, VANGL1, COL1A1, COL1A2, HLA-DRB1, SIGLEC9, LRRC4, CTLA4, JAK3, HLA-DPA1, GPR35, RIPK2, BGN, PTH2R, FOS, SIRT1, F3, LRRC19, PTAFR, KCNA5, PTGS2, FSTL1, FRZB, NTF3, STAT4, FLNA, IL12RB1, IL12RB2, P2RY13, CASP8AP2, P2RY14, USP9Y, TMEM64, COL3A1, HLA-DPB1, LGR4, NCF1, NCF2, NCF4, F13A1, RORA, CXCL13, CTGF, EFEMP1, AP2M1, LAG3, IFNA14, CISH, IFNA16, IFNA10, BLK, CD274, GPR87, TACSTD2, LY96, TNFRSF11A, CORO1A, FOXO1, SOCS2, TNFRSF17, ZNF423, IFNA21, GRIA4, GPR98, TNFRSF10C, TNFRSF10B, BMX, NFKB1, CXCL10, CXCL11, CXCL12, PTPRC, LCN2, HLA-DRA, MYD88, CIITA, ITGAM, ITGB5, ITGB4, LRRK2, ITGB3, ITGB2, PIK3CD, FASLG, ARRB2, ITGAL, TNFSF13B, HHEX, FCGR3A, ITGAX, ITGB8, ITGB7, ITGB6, ITGA4, TNFRSF1B, ITGA7, BIRC5, LCP2, LCP1, BIRC2, BIRC3, IL2RG, TSPAN33, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, FCGR1A, FCGR1B, CTHRC1, TSPAN15, TSPAN13, FCGR2A, IL2RB, PTPN6, CD247, FCGR2B, ICAM2, ICAM3, IFI30, ICAM1, TNFSF11, TRIM25, EPHB2, EPHB1, RSAD2, HNF1B, MIF, EREG, BTC, SFRP4, SFRP2, IFI27, BTK, EPHA3, EPHA2, SDC2, TGFA, PIK3R3, TSPAN8, CD19, TSPAN5, TSPAN2, CD14, PAG1, CCR1, EGR1, TNFSF14, TNFSF12, TNFSF13, PPBP, PILRA, PTK2, ID1, CD28, SDC1, CD27, CD24, IGHM, NRP1, PTPRR, NRP2, CD40, TNFRSF13B, GRIK3, CD3G, PTPRK, CD3E, CD3D, CCR9, FCER1A, MUC13, CD38, CD37, CCR7, CCR6, MUC15, CD36, CCR5, CCR2, IL10, CD53, FCER1G, SYK, GAB1, IL18, GAB2, RGMA, LAT2, IL1A, IL1B, KIT, IGHD, GNAI2, PAK1, IGKC, PERP, IL32, CD74, IL33, SORT1, OSM, IL18R1, IL17A, CD86, CD80, TRAC, MPL, IHH, CELSR1, CCRL2, IL6R, PDGFRB, CD97, PDGFRA, THEMIS, CYBB, GEM, MUC3B, PDGFRL, OSCAR, DOK2, TYROBP, CD8B, CCNE1, CD8A, CARD11, TCF7, PSEN2, KIR2DL1, RASGRP4, VCAM1, CAV2, CRIM1, ISG15, INHBA, VIL1, GH1, IL6, BMP2, GNAQ, IL7R, IGKV3-20, PLEK, SIRPB1, GHR, GRM5, NUP62, MMP1, MMP2, IRAK3, MMP9, IRF7, BCL2A1, SAMHD1, EGF, MX2, MAPK14, SOD2, CD2, CD4, CD6, CD7, CD9, TEK, CDA, CYFIP1, CLEC10A, EPS8, STMN1, GPR171, HOMER3, JUNB, DAPK1, PRKCE, PRKCD, HOXB9, DAAM2, PRKCQ, MAML3, PRKCZ, FLRT2, PLCG2, HMOX1, NCKAP1L, PLCG1, IGHA1, HLA-DQA2, HLA-DQA1, FZD1, FZD5, FZD8, GP6, SNAI2, CDK14, DENND1B, ITK, CDKN1A, TGFB1I1, ASGR2, TIMP1, ANXA1, SERPINB2, IFNGR1, NFAM1, IFNGR2, AES, FCER2, PLCB1, HBEGF, ENG, HLA-DQB1, CCL13, ALOX5, CCL19, CCL18, GPR157, CCL23, CCL21, CCL20, CARD9, NR1H4, G0S2, SULF1, SULF2, ZYX, PLP1, PF4, SEMA5B, CSF3, CSF3R, PLXND1, FMR1, ITGA2B, IL5RA, TNF, FGF5, PYCARD, CDH5, IGHG1, CDH3, FCGRT, GRAP2, IL13RA2, IL13RA1, TLE4, RNF43, SEMA6A, CLEC4A, CLEC4D, ADAM9, CLEC4E, CSF1R, CD151, CALCRL, CUL5, IGLV1-44, EIF2B3, DAB2, BCL6, BCL2, PLXNB2, CSPG4, LAT, BCL2L1, PTPN22, PIK3C2A, ADAMTS1, CR2, CR1, CHUK, LCK, ESRP1, IL3RA, XCL2, XCL1, CX3CR1, CEBPA, CEBPD, NOD2, P2RY6, PLN, P2RY2, POLR2E, IL21R, CSK, POLR2I, POLR2J, POLR2K, POLR2L, SEMA4B, KLF4, PML, P2RX5, KLF6, P2RX1, MNDA, CLEC2D, IL1RN, IFIT1, IFIT3, IFIT2, EDNRB, ICOSLG, SOX4, ACSL1, IL1R1, IL1R2, HLA-B, FLT3LG, HLA-C, HLA-A, HLA-F, HLA-G, RUNX2, HLA-E, IL23A, TLN1, PFN1, IGSF6, SH2D2A, TXK, TWIST1, APCDD1, CD79B, CD79A, INPP5D, CCR10, LIF, NMBR, MARCO, IFNA5, ROBO2, IFNA4, IFNA7, IFNA2, PRL, IFNA8, FFAR2, EDN1, GP1BB, GPBAR1, GP1BA, PDCD1LG2, LIME1, IL17RB, VAV1, HCK, CEACAM1, RHOU, TLR4, TLR2, GUCY2C, SP100, CXCR5, IFI6, CXCR4, CXCR6, LILRA1, LILRA2, CXCR1, CXCR3, CXCR2, LILRB1, LILRB2, SORBS1, LILRB3, PODN, KRT19, CD40LG, FCN1, IL18RAP, ARHGDIA, MATK, TSC2, COL4A2, KIF16B, COL4A1, KLRF1, PRTN3, KLRB1, C5AR1, CSF2RB, ADRB2, DTX3, CSF2RA, STAP1, KLRC1, BTNL8, TGFB2, STIL, TGFB1, NR4A2, NFKBIA, NR4A3, FES, KLRD1, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, OASL, TMEM100, LRRTM4, BLNK, PDE4B, DCC, GLP2R, PLAUR, AXIN2, DCN, TGFBR3, FGR, ZAP70, IFNG, OAS1, OAS3, LTA, LTB, CDH17, CAMK2D, CLEC12B, LEF1, DLL1, GMDS, REPS2, S1PR3, NCAM1, TRAT1, TSHR, LTBR]
GO:0048864;stem cell development;4.0;0.8436909121759173;0.6718454560879586;9.34084218004034;32.15320660831846;6.375876246018314;0.001076138889173156;0.576062607729944;[EDN1, JAG1, EDNRA, PTPRC, SNAI2]
GO:1901216;positive regulation of neuron death;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;58.38287487682085;5.370354380416217;0.001954022280951067;0.5977604853516485;[ITGAM, CTSZ, ITGB2, FASLG, CLU, MYB, FOS, KMO, CDC34, IL1B, TLR6, TLR4, TP53BP2, FYN, SNCA, EGR1, JUN, TGFB2, EIF2S1, FCGR2B, UBE2M]
GO:0007569;cell aging;3.0;0.7980440201809971;0.597142322680643;8.935377071932177;24.751975343904395;5.618190544320798;8.284263394289076E-4;0.485434838299289;[CDKN1A, SERPINE1, BRCA2, ICAM1, NUP62, CHEK1, MME, PRKCD, H2AFX, HMGA1, MIF, MAPK14, SIRT1, PML, DNAJA3, CDK1, BCL2, NOX4, ENG]
GO:0006357;regulation of transcription by RNA polymerase II;10.0;0.43649654099988644;0.6334892823608635;7.109131426632953;248.56913769389934;1.8913682364374496;0.008319385340914571;0.5119656714299493;[PID1, SPI1, EHMT2, SLA2, SPIB, AKT1, MNX1, MEF2A, MEF2C, ZFYVE16, ATF3, GATA3, GATA1, HESX1, JUN, JAG1, JUP, NR2F2, PKIG, EZH2, HOXC10, RIPK2, ACTL6A, FOS, SIRT1, MMP12, MED23, PLSCR1, CKS2, PTAFR, FSTL1, STAT4, ZNF467, USP9Y, ATAD2, NOC3L, PSMC6, PSMC2, PKN1, CCNT2, RORA, RUVBL2, RUVBL1, ADCYAP1, MAZ, FOXO1, ZNF423, NFKB1, NFKB2, CXCL10, CIITA, FHL2, FASLG, ARRB1, HHEX, PPP1R12A, PEG3, LRP2, E2F1, E2F2, E2F5, E2F7, PRRX1, POU2AF1, SMARCAL1, CCNH, CCNC, IKZF1, UXT, TNFSF11, HNF1B, SFRP4, SFRP2, IFI27, TGFA, PCBP3, ZNF700, EGR1, EGR2, EGR3, ID1, CD28, ECM1, CD40, SUV39H1, HNF4G, BRCA1, PCSK6, BMI1, CD3D, HNF4A, CD36, IL10, IL18, RGMA, IL1A, IL1B, KIT, YAP1, SATB2, RXRA, IL33, OSM, NEDD4, FOXA3, IL17A, FOXA2, IHH, ETS1, NR3C2, LOXL2, EOMES, CCNE1, TCF7, HTRA1, VDR, CAV1, HMGA1, INHBA, IL6, BMP2, TCF4, MXD1, FBN1, PLEK, HMGB2, ARHGEF10L, LYL1, MYBL1, MYOCD, DDX58, ETV1, GREM1, ELF3, IRF7, ZMYND11, FBP1, CREB5, TAF9, AURKB, TBX21, MAPK14, SOD2, EHF, SERPINE1, HOXA9, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, HOXA4, MED1, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB6, HOXB5, RAD21, PRDM16, HMOX1, ELANE, NKX2-3, FZD1, NFE2, FZD5, PLK1, FZD8, SNAI2, CDKN1A, BTG2, ZNF367, HAVCR2, BRD2, PAWR, PAX5, PAX2, AES, RARA, ENG, NR1I2, ASCL2, EPCAM, NR1H2, NR1H4, GTF2H1, ELP4, SULF1, POU4F1, FOSB, PF4, CSF3, PLXND1, TNF, DACH1, MEN1, TLE4, AEBP1, NACC2, WFS1, HOPX, COPS5, MAFB, BCL6, MAFF, BCL3, CYR61, RFC1, CHUK, TFDP1, CEBPA, CEBPB, HDAC2, SMARCD3, CEBPD, CEBPE, NOD2, ABLIM3, RBBP8, IRX3, KLF4, PML, KLF1, KLF8, KLF6, KLF5, DNAJA3, PPIL4, GFI1, ZNF608, EDNRB, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, IL23A, PFN1, BEX1, TXK, TWIST1, NHLH2, BCL11B, BCL11A, LIF, TOP2A, AHCTF1, PRL, XPO1, EDN1, PARP9, TFEC, TLR4, TLR2, SP100, PURA, CDX2, CDX1, LILRB1, GRHL2, CAMK1, ARID4A, ARID4B, HOXA11, HOXA10, CHCHD3, LMO2, ADRB2, NLRP3, TGFB2, TGFB1, CBX4, NR4A2, NFKBIA, NR4A1, NR4A3, FEV, JMY, CREBZF, KDM5D, SLC40A1, TMEM100, KLF12, KLF13, CKAP2, DCN, TGFBR3, IFNG, CAMK2D, LEF1, DLL1, HSPD1, HLX, SNCA, LUM, MEIS2, MEIS1, RBMX]
GO:0002399;MHC class II protein complex assembly;7.0;1.0;0.8509193652572005;9.628524252492122;45.61567929762514;9.777073627680469;0.0015267157346454312;0.8509193652572005;[HLA-DMB]
GO:0070493;thrombin-activated receptor signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.976932752798508;7.57984905034425;9.028936615729279E-4;0.710754145523778;[F2R, PLEK, GP1BA, F2RL3]
GO:0001975;response to amphetamine;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;70.50276562849314;6.558197802812269;0.0023596641172160164;0.6585068532133508;[NR4A2, HDAC2, DRD4, ICAM1]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[CD86, CXCL6, CXCL9, CD40, IL1RN, CSF3, CD80, GFI1, SERPINE1, HMGB2, TNFAIP3, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, ICAM1, PYCARD, EDNRB, PDE4B, CTSG, CD36, CCR5, HAVCR2, IL10, GHSR, MEF2C, ARG1, CD180, PDCD1LG2, TNFRSF1B, IL1B, RARA, ADAM9, TLR4, CX3CR1, CD274, CEBPB, CEBPE, KLRK1, STAP1, NLRP3, CCL2, CD14, ABCA1, CCL20, NR1H2, DEFA4, NR1H4, LILRB1, DEFA1, LILRB2, PPBP, MAPK14, NFKB1, CXCL10, CXCL11, IL6, PF4]
GO:0045123;cellular extravasation;6.0;0.7671156992804218;0.7066781622303554;8.999915593069748;29.137022145890857;7.379178354882098;9.751899096054872E-4;0.7004918368257019;[ITGB2, PECAM1, CCL2, PIK3CD, PRTN3, AZU1, CD177, ICAM1]
GO:0030836;positive regulation of actin filament depolymerization;11.0;0.8259837884571596;0.845420846558242;9.503361109538115;392.2090701602175;7.212124270218933;0.013126884613015779;0.8012573229067359;[VIL1, PLEK]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[SERPINE1, PHB2, AKT1, PROK2, IER3, MED1, MEF2C, PRKCH, DAPK1, PRKCD, CLDN7, PRKCQ, GATA3, SLC30A10, GATA1, PRKCZ, FIGNL1, HMOX1, SFN, NCKAP1L, BARD1, JUN, PLK2, PLK1, EIF2AK2, AZU1, SNAI2, CDKN1A, BTG2, CHL1, TIMP1, JAK3, ANXA1, SERPINB2, DUSP1, RIPK2, ANXA5, SERPINB9, SIRT1, PAX2, RARA, PTGS2, UNG, NTF3, FLNA, CCL19, CCL21, GABRA5, NR1H4, POU4F1, FABP1, PF4, TNF, CLU, LAMP3, CLEC5A, F2R, ADCYAP1, MSH2, ADAM8, CSF1R, BLM, CORO1A, FOXO1, SOCS2, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, DAB2, CXCL12, COPS5, BCL6, BCL3, CDK1, BCL2, MYD88, BCL2L1, LRRK2, FHL2, FASLG, ARRB1, ARRB2, CYR61, TNFRSF1B, ADAMTS20, BIRC5, BIRC2, BIRC3, CX3CR1, CEBPB, HDAC2, LRP1, NLRC4, NOD2, CCL5, CCL2, FYN, TIE1, KLF4, IL2RB, EVI2B, IL1RN, SLC46A2, IFIT3, AQP1, ICAM1, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB2, EPHB1, FLT3LG, HNF1B, MIF, BTC, POR, SFRP2, EPHA3, NAIP, EPHA2, TWIST1, PKHD1, EGR3, BCL11B, TNFSF14, PTK2, VNN1, ID1, CD28, CD27, NRP1, BRCA1, CTSH, CD38, CCR7, CCR5, IL10, EDN1, FCER1G, STRADB, HCK, RNF144B, IL1A, CEACAM6, IL1B, CEACAM5, KIT, YAP1, IFI6, AIF1, GNAI2, CXCR2, PDPN, CTNNA1, CD74, LILRB1, CD40LG, GRINA, MAD2L1, ZFAND6, IHH, MPO, COMP, ARHGDIA, PDGFRB, GHSR, PDGFRA, C5AR1, PSEN2, ALOX12, STIL, CBX4, CAV1, NR4A2, NFKBIA, VIL1, IL6, NR4A3, NAT8, IL7R, TNFAIP8, HMGB2, SLC40A1, TNFAIP3, NUP62, MYOCD, PLAUR, MMP9, GREM1, NDUFS3, IRF7, ZMYND11, LTF, BCL2A1, TAF9, LEF1, DLL1, THBS1, AURKB, HSPD1, SNCA, SOD2, TEK, NAA15]
GO:0006904;vesicle docking involved in exocytosis;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;32.65265176272962;6.039404009397101;0.0010928548690198408;0.6319757144917204;[STXBP2, PLEK, CFTR]
GO:0030838;positive regulation of actin filament polymerization;11.0;0.7866048967936545;0.8257314007264895;9.456673995565463;459.92540939869633;5.2552850506314295;0.01539328954657896;0.7011844742147011;[CYFIP1, CSF3, LMOD1, ICAM1, PYCARD, CCR7, PRKCE, HCK, PFN1, NCKAP1L, VASP, GSN, CCL21, VIL1, JMY]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[PHB2, TNF, CTGF, ICAM1, PYCARD, TNFSF11, EPHB2, EPHB1, PDGFRB, PDGFRA, F2R, MIF, ADCYAP1, EPHA3, EPHA2, CSF1R, C5AR1, PDGFA, FPR2, TNFRSF11A, SLC30A10, PRKCZ, RASGRP1, PDGFD, PDGFC, SLAMF1, CCR1, JUN, TGFB1, MARCO, BMP2, NOX4, NRP1, TREM2, PTPN22, ARRB1, ARRB2, CCR7, CD36, HAVCR2, RIPK2, IL1B, KIT, XCL2, CHI3L1, XCL1, CCL13, NOD2, GNAI2, CCL8, GPNMB, CCL7, CCL5, CCL4, CCL2, CCL1, CCL19, CCL18, CD74, CCL23, CCL21, CCL20, TIE1, CD4, TEK]
GO:0071347;cellular response to interleukin-1;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.446340287394138;0.0027327542132076126;0.6016464081682054;[CCL13, CD40, CEBPB, RORA, ADAMTS12, ICAM1, PYCARD, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, EDN1, CCL21, CCL20, KMO, NFKB1, MAPK13, XCL2, CHI3L1, XCL1, RBMX, IL17A]
GO:0071346;cellular response to interferon-gamma;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[HLA-DPA1, EDN1, DAPK1, KIF16B, XCL2, XCL1, TLR4, TLR2, CCL13, STXBP2, AIF1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, IL12RB1, CCL23, GSN, CCL21, CCL20, ZYX]
